Biotech

All Articles

Merck- Gilead long-acting oral combination reduces HIV for 48 full weeks

.Gilead Sciences as well as Merck &amp Co. have actually directed their once-weekly HIV mixture ther...

Lykos allows FDA look at that MDMA approval relies on new test

.Lykos Rehabs may have shed three-quarters of its own personnel following the FDA's rejection of its...

Septerna intends $158M IPO to fund readouts for GPCR pipe

.Septerna might be actually yet to divulge "any sort of meaningful clinical records," but the biotec...

AvenCell bags $112M to snap 'switchable' CAR-Ts in the medical clinic

.AvenCell Rehabs has secured $112 thousand in set B funds as the Novo Holdings-backed biotech finds ...

China- based biotech strategies ph. 3 after viewing midstage eye data

.China-based Minghui Pharmaceutical has actually connected its own thyroid eye health condition proc...

Sangamo slashes opportunity to market for Fabry genetics treatment as FDA accepts increased permission package

.Sangamo Therapeutics has recognized a faster way to market for its own Fabry illness applicant, str...

Otsuka's renal illness medicine boosts UPCR degrees in ph. 3 trial

.Otsuka Pharmaceutical's renal illness medication has attacked the key endpoint of a period 3 trial ...

Roche scraps $120M tau possibility, coming back legal rights to UCB

.Roche has given back the civil rights to UCB's anti-tau antitoxin bepranemab, ignoring a $120 milli...

Editas strengthens in vivo strategy by means of $238M Genenvant pact

.Editas Medicines has signed a $238 thousand biobucks treaty to integrate Genevant Science's crowd n...

Combo end results, Vicodin miss and celestial protection

.Vertex has disclosed stage 3 data on its own near-approval pain medicine candidate suzetrigine, cla...